Read-through Therapy
Read-Through Therapy is a therapeutic strategy in molecular medicine that functions as a pharmacological intervention designed to induce ribosomal read-through of premature termination codons in mutant mRNA transcripts, thereby enabling the production of full-length functional proteins in genetic disorders such as Epidermolysis Bullosa.
22
Publications
1.2K
Citations
174
Authors
75
Institutions
Publications per year
2017–2026
12
Variants
Read-through PharmacotherapyStop-codon Read-through Therapy
Parents
22
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study
Marcella Neri, Rachele Rossi, Cecilia Trabanelli et al. · Frontiers in Genetics · 2020 · 84 citations · Full text
1–5 of 22
174
4
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 174
75
Johannes Gutenberg University Mainz
Mainz, Germany
4 h-index
13 publications
820 citations

Hadassah Medical Center
Jerusalem, Israel
3 h-index
7 publications
134 citations
Stony Brook University
Stony Brook, United States
2 h-index
8 publications
200 citations
Hebrew University of Jerusalem
Jerusalem, Israel
2 h-index
6 publications
79 citations
Cold Spring Harbor Laboratory
Cold Spring Harbor, United States
2 h-index
14 publications
350 citations
Technion – Israel Institute of Technology
Haifa, Israel
2 h-index
4 publications
246 citations
University of California, Los Angeles
Los Angeles, United States
2 h-index
16 publications
1.7K citations

Karolinska Institutet
Stockholm, Sweden
2 h-index
7 publications
1.1K citations
1–8 of 75
IJMS · 3 publications · 73 citations
3
h-index
PNAS · 2 publications · 199 citations
2
h-index
CEP · 1 publications · 25 citations
1
h-index
Repository · 1 publications · 13 citations
1
h-index
1 publications · 136 citations
1
h-index
1–5